These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7195061)

  • 21. On the treatment of onchocerciasis in Sudan.
    Abdel Fattah A; Youssif NM; Shenouda OA; Morsy TA
    J Egypt Soc Parasitol; 1985 Jun; 15(1):329-33. PubMed ID: 4056479
    [No Abstract]   [Full Text] [Related]  

  • 22. [Attempt at a collective treatment with diethylcarbamazine in a village in the region of Bamako (Mali) where onchocerciasis is hyperendemic].
    Rougemont A; Boisson ME; Borges da Silva G; Zander N
    Bull World Health Organ; 1976; 54(4):403-10. PubMed ID: 1088353
    [No Abstract]   [Full Text] [Related]  

  • 23. Suramin and therapy of onchocerciasis.
    Coyne PE; Maxwell C
    Arch Dermatol; 1992 May; 128(5):698. PubMed ID: 1575537
    [No Abstract]   [Full Text] [Related]  

  • 24. The natural history of ocular onchocerciasis over a period of 14--15 years and the effect on this of a single course of suramin therapy.
    Budden FH
    Trans R Soc Trop Med Hyg; 1976; 70(5-6):484-91. PubMed ID: 841651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Eye involvement in onchocerciasis].
    Gornig H
    Klin Monbl Augenheilkd; 1967; 151(1):108-11. PubMed ID: 5595968
    [No Abstract]   [Full Text] [Related]  

  • 26. The risk of optic atrophy following suramin treatment of ocular onchocerciasis.
    Thylefors B; Rolland A
    Bull World Health Organ; 1979; 57(3):479-80. PubMed ID: 314359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of enzymatically isolated adults of Onchocerca volvulus after treatment of patients with suramin or metrifonate.
    Wolf H; Schulz-Key H; Albiez EJ; Geister R; Büttner DW
    Tropenmed Parasitol; 1980 Jun; 31(2):143-8. PubMed ID: 7414675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationships between the burden of adult parasites, host age and the microfilarial density in human onchocerciasis.
    Duerr HP; Dietz K; Schulz-Key H; Büttner DW; Eichner M
    Int J Parasitol; 2004 Mar; 34(4):463-73. PubMed ID: 15013736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of 3 years ivermectin treatment on onchocerciasis in Yanomami communities in the Brazilian Amazon.
    Banic DM; Calvão-Brito RH; Marchon-Silva V; Schuertez JC; de Lima Pinheiro LR; da Costa Alves M; Têva A; Maia-Herzog M
    Acta Trop; 2009 Nov; 112(2):125-30. PubMed ID: 19615327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [International cooperation at the services of 7 African countries: fight against onchocerciasis in the basin of the Volta River].
    Bernard L
    Schweiz Rundsch Med Prax; 1974 Dec; 63(50):1520. PubMed ID: 4475422
    [No Abstract]   [Full Text] [Related]  

  • 31. Suramin: with special reference to onchocerciasis.
    Hawking F
    Adv Pharmacol Chemother; 1978; 15():289-322. PubMed ID: 358805
    [No Abstract]   [Full Text] [Related]  

  • 32. A longitudinal study of impact of repeated mass ivermectin treatment on clinical manifestations of onchocerciasis in Imo State, Nigeria.
    Emukah EC; Osuoha E; Miri ES; Onyenama J; Amazigo U; Obijuru C; Osuji N; Ekeanyanwu J; Amadiegwu S; Korve K; Richards FO
    Am J Trop Med Hyg; 2004 May; 70(5):556-61. PubMed ID: 15155991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Onchocercosis: criteria of evaluation of results in a rural therapeutic campaign].
    Degabriel J; Lucot J; Chovet M
    Med Trop (Mars); 1970; 30(6):795-800. PubMed ID: 5534309
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunological status of onchocerciasis patients and its changes during diethylcarbamazine and suramin treatment (a review of the literature)].
    Ovusu A
    Med Parazitol (Mosk); 1983; (5):81-7. PubMed ID: 6358827
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ocular manifestations associated with vitamin A deficiency in a rural area of Burkina Faso].
    Meda N; Chevalier P; Mathieu-Daude C
    Med Trop (Mars); 2000; 60(1):57-60. PubMed ID: 10989789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pilot project for a medical treatment campaign against onchocerciasis based upon the administration of suramin sodium (U.S. P. XIII). II. Treatment and follow-up examination].
    BURCH TA; AGUILAR GG; BARRERA M; DALMAT HT
    Bol Oficina Sanit Panam; 1955 Feb; 38(2):141-7. PubMed ID: 14378374
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pilot project for a medical treatment campaign against onchocerciasis based upon the administration of suramin sodium (USP XIII). I. Pretreatment survey].
    BURCH TA
    Bol Oficina Sanit Panam; 1955 Jan; 38(1):20-5. PubMed ID: 14363376
    [No Abstract]   [Full Text] [Related]  

  • 38. The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on onchocerciasis in Uganda.
    Ndyomugyenyi R; Tukesiga E; Büttner DW; Garms R
    Trop Med Int Health; 2004 Aug; 9(8):882-6. PubMed ID: 15303993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Onchocerciasis.
    Somorin AO
    Int J Dermatol; 1983 Apr; 22(3):182-8. PubMed ID: 6853010
    [No Abstract]   [Full Text] [Related]  

  • 40. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues.
    Katabarwa M; Eyamba A; Habomugisha P; Lakwo T; Ekobo S; Kamgno J; Kuete T; Ndyomugyenyi R; Onapa A; Salifou M; Ntep M; Richards FO
    Trop Med Int Health; 2008 Sep; 13(9):1196-203. PubMed ID: 18631308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.